hereditary angioedema

Ask MedXY AI

Latest news

Tag

Allergy & Immunologylong-term prophylaxissebetralstat

Oral Sebetralstat Shows Rapid Relief for Breakthrough Attacks in HAE Patients on Long-Term Prophylaxis: Interim Analysis of KONFIDENT-S

By MedXY|Jul 26, 2026

An interim analysis of the KONFIDENT-S open-label extension shows that oral sebetralstat is well tolerated and provides rapid symptom relief for breakthrough attacks in HAE patients on long-term prophylaxis.

Clinical Updateshereditary angioedemaoral therapy

EMA Recommends First Oral On-Demand Therapy for Hereditary Angioedema: A Paradigm Shift in Acute Attack Management

By MedXY|Sep 30, 2025

EMA endorses sebetralstat, the first oral on-demand therapy for hereditary angioedema, following positive results from the KONFIDENT phase 3 trial, offering a more convenient and rapid treatment option for acute attacks.